MedTrace Logo

Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer

NCT05208372 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-01-26

No results posted yet for this study

Summary

To investigate the value of CTCs and ctDNA in the diagnosis of metastasis in ascites/peritoneal flushing fluid and blood; To investigate the influence of laparoscopic CO2 pneumoperitoneum establishment on peritoneal and hematogenous metastasis of advanced gastric cancer; To explore the influence of the number and type of CTCs and ctDNA on metastasis and prognosis.

Conditions

  • Stomach Neoplasms
  • Metastasis

Interventions

DIAGNOSTIC_TEST

CTC test

Circulating tumor cells test of ascites and blood for patients with gastric cancer.

DIAGNOSTIC_TEST

ctDNA test

Circulating tumor DNA test of ascites and blood for patients with gastric cancer.

Sponsors & Collaborators

  • First Hospital of China Medical University

    lead OTHER

Principal Investigators

  • Kai Li, MD · First Hospital of China Medical University

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-02-01
Completion
2024-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05208372 on ClinicalTrials.gov